Search Results 1051-1060 of 19002 for Neutrophil

  1. Carfilzomib and Melphalan Before Stem Cell Transplant in Treating Patients With Multiple Myeloma - Mayo Clinic

    Absolute neutrophil count >= 1000/uL; Platelet count >= 50,000/uL; Hemoglobin >= 8.0 g/dL; Diagnosis of symptomatic MM; Measurable disease of multiple myeloma ...

  2. BiCaZO: A Study Combining Two Immunotherapies (Cabozantinib and Nivolumab) to Treat Patients With Advanced Melanoma or Squamous Cell Head and Neck Cancer, an immunoMATCH Pilot Study - Mayo Clinic

    - Leukocytes ≥ 3,000/uL (within 28 days prior to step 2 registration). - Absolute neutrophil count ≥ 1,500/uL (within 28 days prior to step 2 registration) ...

  3. Cyclophosphamide, Carfilzomib, Thalidomide, and Dexamethasone in Treating Patients With Newly Diagnosed Active Multiple Myeloma - Mayo Clinic

    Absolute neutrophil count ≥ 1000/uL; Platelet ≥ 75000/uL; Hemoglobin ≥ 8.0 g/dL; Untreated symptomatic myeloma: Prior non-systemic therapy for the treatment ...

  4. Pembrolizumab in Treating Patients With Small Bowel Adenocarcinoma That is Metastatic or Locally Advanced and Cannot Be Removed by Surgery - Mayo Clinic

    Absolute neutrophil count (ANC) >= 1500/mm^3 (1.50 x 10^9 /L); Platelet count >= 100,000/mm^3 (100 x 10^9 /L); Hemoglobin >= 9.0 g/dL (5.6 mmol/L or 90 g/L) ...

  5. Akt Inhibitor MK-2206 and Anastrozole With or Without Goserelin Acetate in Treating Patients With Stage II-III Breast Cancer - Mayo Clinic

    Absolute neutrophil count ≥ 1,500/mcL; Platelets ≥ 100,000/mcL; Total bilirubin ≤ upper limit of normal (ULN); Aspartate aminotransferase (AST) (serum ...

  6. A Study to Evaluate Pemetrexed and Pembrolizumab to Treat Recurrent and/or Metastatic Salivary Gland Malignancies - Mayo Clinic

    Absolute neutrophil count (ANC) ≥ 1500/mm^3;; Platelet count ≥ 100,000/mm^3;; Total bilirubin ≤ 1.5 x ULN; Alanine aminotransferase (ALT) and aspartate ...

  7. A Study To Assess The Safety, Tolerability, And Pharmacokinetics Of ABSK-011 In Patients With Advanced Solid Tumor - Mayo Clinic

    Absolute neutrophil count (ANC) ≥1.5×109/L. Platelet count (PLT) ≥75×109/L. Hemoglobin (Hb) ≥80 g/L. Total bilirubin (TBIL) ≤1.5×ULN. Aspartate transaminase ...

  8. A Study to Evaluate HKI-272 and Capecitabine for HER2-Positive Breast Cancer and Brain Metastases - Mayo Clinic

    Absolute neutrophil count > 1,000/uL;; Platelets > 100,000/uL;; Total bilirubin ≤ 1.5 X upper limit of normal (ULN) ;; AST(SGOT)/ALT(SGPT) ≤3 X institutional ...

  9. A Study of Nivolumab and Multi-fraction Stereotactic Radiosurgery with or without Ipilimumab in Treating Participants with Recurrent Grade II-III Meningioma - Mayo Clinic

    Absolute neutrophil count >= 1,500/mcL. Platelets >= 100,000/mcL. Total bilirubin =< 1.5 x institutional upper limit of normal (ULN). Aspartate ...

  10. Cabozantinib-S-Malate in Treating Patients With Refractory Thyroid Cancer - Mayo Clinic

    Absolute neutrophil count >= 1,500/mcL; Platelet count >= 100,000/mcL; Hemoglobin >= 9 g/dL; Thyroid stimulating hormone (TSH) < lower limit of normal (LLN) ...